Genetic breakthrough in childhood kidney cancer
Scientists from the Princess Máxima Center, together with international partners, discovered that a form of kidney cancer in children, Wilms tumor, contains many more genetic changes than previously thought. This discovery could lead to new, more targeted treatment options in the future, including immunotherapy.
Scientists from the Princess Máxima Center, working with partners from the Wellcome Sanger Institute, the University of Cambridge and Great Ormond Street Hospital in the UK, have used new DNA technologies to examine tumors from young children with a kidney tumor in detail. They used advanced sequencing, a method that allows scientists to quickly and extensively read out the entire genetic material of the tumor.
More variation than expected
By genetically mapping individual cells of Wilms tumors, the researchers found many more mutations per cell than expected. Dr. Jarno Drost, research group leader at the Princess Máxima Center and Oncode Institute, is co-senior author of the new study. He says: ‘Our findings show that the genetic variation of some childhood tumors is much higher than previously thought. In some cases, it’s even comparable to that of tumors in adults.’ The findings change the assumptions we had of childhood cancer and also point to opportunities for new or existing therapies.
Implications for treatment
Tumors with a lot of genetic variation can adapt more quickly, so a treatment can stop working. But large variation in the tumor also offers targets for precision therapies such as immunotherapy. These treatments, now mainly used in adult oncology, could in future also be used in children with Wilms tumor.
Unique genetic change in congenital tumors
Another important discovery in the research is a specific genetic change (in the FOXR2 gene) that already occurs during embryonic development. This mutation appears to be responsible for a rare congenital form of Wilms tumor, with specific features under the microscope, and with a characteristic genetic profile. Spotting this mutation could in future help to personalize treatment for children with a Wilms tumor.
Careful balance
Jarno Drost: ‘The treatment of Wilms tumors requires a careful balance: targeting the tumor and preventing the cancer from coming back, with as little impact as possible on the quality of life of a child and their family. We now better understand which genetic changes cause these tumors, and can better pick out these genetic subgroups. Our research marks an important step towards more targeted and child-friendly treatments.’
This study was published today in Nature Communications. The research was led by Dr. Sam Behjati of the Wellcome Sanger Institute in the UK and Dr. Jarno Drost of the Princess Máxima Center and Oncode Institute. The research was funded by the Alpe d’HuZes/KWF fund, ERC, the Wellcome Trust and the Little Princess Trust.
Knot good: How cells untie DNA to protect the genome
Not all DNA looks like the familiar twisted ladder. Sometimes, parts of our genetic code fold into unusual shapes. One such structure, the G-quadruplex (G4), looks like a knot. These knots can play important roles in turning genes on or off. But if not untangled in time, they can harm our genome. Now, researchers from the Knipscheer Group, in collaboration with the Karolinska Institutet, have uncovered a surprising mechanism that keeps these knots in check. Their work, published in Science on June 12th, could lead to new ways to treat diseases like cancer.
Number of animal experiments at Utrecht University and UMC Utrecht declines further in 2024
The number of animal experiments conducted by Utrecht University and UMC Utrecht has declined again over the past year. The numbers dropped from 14,192 in 2023 to 12,584 in 2024. This is evident from the joint 2024 Annual Report on Animal Experiments.
Utrecht Life Sciences: from pitch to practise
On 1st October 2024, Professor Paul Coffer stepped into his role as Scientific Director of Utrecht University’s Strategic Theme Life Sciences. More than six months in, the honeymoon period is over and the course ahead is clear. What did he encounter, and where is he heading next?
Record number of participants cross the finish line at the sunny Utrecht Science Park during the HiPRO Utrecht Marathon
On Sunday 18 May, Utrecht was all about sports. The HiPRO Utrecht Marathon experienced a special edition with a full lap at the marathon distance and a record number of participants of over 18,500. In the morning, thousands of runners started their run. Traditionally, the start and finish took place at the Utrecht Science Park, which was the vibrant heart of this sports event.